Age and gender may influence patient outcomes following gene therapy to treat incurable eye diseases.
A study conducted by researchers at the University of Bristol revealed how age and gender affects inflammation caused by gene therapy treatments and could cause damage to the eye.
They published their findings in Molecular Therapy.
Ophthalmology Times Europe has more.